Bristol-Myers Squibb Company's functional peer companies ranked by peer score — growth, valuation, profitability and stability compared.
| Comparison | BMY peer score | |
|---|---|---|
|
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.
|
70 | Compare → |
|
Bristol-Myers Squibb Company vs AbbVie Inc.
|
44 | Compare → |
|
Bristol-Myers Squibb Company vs Merck & Co., Inc.
|
63 | Compare → |
|
Bristol-Myers Squibb Company vs Biogen Inc.
|
26 | Compare → |
|
Bristol-Myers Squibb Company vs EMS-CHEMIE HOLDING AG
|
67 | Compare → |
|
Bristol-Myers Squibb Company vs Electronic Arts Inc.
|
40 | Compare → |
|
Bristol-Myers Squibb Company vs Pentair plc
|
56 | Compare → |
|
Bristol-Myers Squibb Company vs Illumina, Inc.
|
59 | Compare → |
|
Bristol-Myers Squibb Company vs The Coca-Cola Company
|
69 | Compare → |
|
Bristol-Myers Squibb Company vs F5, Inc.
|
65 | Compare → |
|
Bristol-Myers Squibb Company vs Brown-Forman Corporation
|
62 | Compare → |
View the complete Bristol-Myers Squibb Company report including all peer dimensions.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.